Editorial: Emerging targeted and immunotherapeutic strategies in oncology: from solid tumors to hematologic malignancies
Cancer remains among the leading causes of death worldwide, with an estimated 20 million new cases and nearly 10 million deaths in 2022 and a burden projected to grow substantially over the coming decades [1]. The conceptual framework of cancer as a disease of dysregulated hallmark capabilities, sustained proliferation...
Ximena Maria Mureșan, Adrian Bogdan Tigu, Andrei Roman et al.
· Frontiers in Pharmacology · 0 citations